Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Mustang Bio Inc MBIO

Healthcare Biotechnology
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating medical breakthroughs in cell and gene therapies into potential cures for cancers and rare genetic diseases. The Company has partnered with medical institutions to advance the development of chimeric antigen receptor modified T cell (CAR-T) therapies across multiple cancers, as well as lentiviral gene... see more

Recent & Breaking News (NDAQ:MBIO)

Mustang Bio Announces Key Leadership Appointments

GlobeNewswire March 15, 2018

Mustang Bio to Present at March Investor Conferences

GlobeNewswire March 13, 2018

Mustang Bio to Present at the 255th American Chemical Society National Meeting & Exposition

GlobeNewswire March 12, 2018

Mustang Bio to Participate in Immuno-Oncology Panel at BIO CEO & Investor Conference

GlobeNewswire February 6, 2018

Mustang Bio to Participate in LifeSci Advisors Corporate Access Event in San Francisco, January 8 – 10, 2018

GlobeNewswire December 14, 2017

Fortress Biotech Announces Positive Clinical Data From Fortress Companies Presented at the 59th American Society of Hematology Annual Meeting

GlobeNewswire December 11, 2017

Mustang Bio's MB-102 (CD123 CAR) CAR T Therapy Achieves Complete Response in Acute Myeloid Leukemia and Blastic Plasmacytoid Dendritic Cell Neoplasm in Phase 1 Clinical Trial

GlobeNewswire December 11, 2017

Mustang Bio Announces License Agreement with Harvard University, and Research Collaboration with Beth Israel Deaconess Medical Center, to Develop CRISPR/Cas9-Enhanced CAR T Therapies

GlobeNewswire December 4, 2017

Mustang Bio Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights

GlobeNewswire November 14, 2017

Mustang Bio Announces Appointment of Brian Achenbach as Vice President of Finance and Corporate Controller

GlobeNewswire November 14, 2017

Mustang Bio Announces MB-102 Data Selected for Oral Presentation at 59th American Society of Hematology Annual Meeting

GlobeNewswire November 1, 2017

Mustang Bio Reports Preclinical Data on Regional Delivery of MB-103 HER2 Chimeric Antigen Receptor Engineered T (CAR T) Cells to Target HER2+ Breast Cancer Metastasis to the Brain

GlobeNewswire October 31, 2017

Mustang Bio Establishes CAR T Cell Therapy Manufacturing Facility in Massachusetts

GlobeNewswire October 30, 2017

Mustang Bio Announces $12.8 Million Grant to Fund Phase 1 Trial of CAR T Therapy MB-101 in Malignant Glioma

GlobeNewswire October 11, 2017

Mustang Bio Announces Expansion of CAR T Pipeline into CD20-Directed Immunotherapies

GlobeNewswire September 14, 2017

Mustang Bio to Present at the CAR-TCR Summit 2017

GlobeNewswire September 5, 2017